Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-26.00	57.73	78.01
Graham Fair Price	-50.10	15451.27	30967.13
PEG	-90.20	1.20	12.21
Price/Book	-3.66	0.39	0.40
Price/Cash Flow	19.24	-11.86	-14.69
Prices/Earnings	-280.37	-89.62	-23.56
Price/Sales	-1.39	1.08	1.10
Price/FCF	19.24	-11.86	-14.69
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	14.26	0.13	0.12
Operating Margin	-6.34	< 0.005	< 0.005
ROA	76.47	< 0.005	< 0.005
ROE	< 0.005	< 0.005	74.67
ROIC	< 0.005	-0.01	-1144.06
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.20	-0.05	289.61
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.15	1.91	1198.89
EPS QOQ	0.02	0.75	3781.81
FCF QOQ	-2.26	-0.18	91.90
Revenue QOQ	-0.03	-0.03	-0.59
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.07	76.55	7.71
Days Sales Outstanding (DSO)	80.76	90.34	11.86
Inventory Turnover	1.27	1.18	-7.16
Debt/Capitalization	0.35	0.40	12.89
Quick Ratio	0.75	0.78	3.73
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	100047.15	99188.35	-0.86
Cash	17718.08	25611.24	44.55
Capex	-2458.62	-2970.08	-20.80
Free Cash Flow	-2733.03	-3232.59	-18.28
Revenue	36657.71	35506.80	-3.14
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.16	1.15	-1.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	43.28	34.19	-21.00
Naive Interpretation	Member

06 - Financial Health · Bad

Rating